Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;51(12):9394-9404.
doi: 10.1002/mp.17442. Epub 2024 Oct 6.

Toward widespread use of virtual trials in medical imaging innovation and regulatory science

Affiliations
Review

Toward widespread use of virtual trials in medical imaging innovation and regulatory science

Ehsan Abadi et al. Med Phys. 2024 Dec.

Abstract

The rapid advancement in the field of medical imaging presents a challenge in keeping up to date with the necessary objective evaluations and optimizations for safe and effective use in clinical settings. These evaluations are traditionally done using clinical imaging trials, which while effective, pose several limitations including high costs, ethical considerations for repetitive experiments, time constraints, and lack of ground truth. To tackle these issues, virtual trials (aka in silico trials) have emerged as a promising alternative, using computational models of human subjects and imaging devices, and observer models/analysis to carry out experiments. To facilitate the widespread use of virtual trials within the medical imaging research community, a major need is to establish a common consensus framework that all can use. Based on the ongoing efforts of an AAPM Task Group (TG387), this article provides a comprehensive overview of the requirements for establishing virtual imaging trial frameworks, paving the way toward their widespread use within the medical imaging research community. These requirements include credibility, reproducibility, and accessibility. Credibility assessment involves verification, validation, uncertainty quantification, and sensitivity analysis, ensuring the accuracy and realism of computational models. A proper credibility assessment requires a clear context of use and the questions that the study is intended to objectively answer. For reproducibility and accessibility, this article highlights the need for detailed documentation, user-friendly software packages, and standard input/output formats. Challenges in data and software sharing, including proprietary data and inconsistent file formats, are discussed. Recommended solutions to enhance accessibility include containerized environments and data-sharing hubs, along with following standards such as CDISC (Clinical Data Interchange Standards Consortium). By addressing challenges associated with credibility, reproducibility, and accessibility, virtual imaging trials can be positioned as a powerful and inclusive resource, advancing medical imaging innovation and regulatory science.

Keywords: computational phantoms; credibility; imaging simulators; in silico trials; informatics; medical imaging simulations; reproducibility; simulations; virtual imaging trials.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

Ehsan Abadi has a relationship with Siemens Healthineers and Silomedics, LLC. Nick Bottenus has a relationship with Microelastic Ultrasound Inc. Alejandro Frangi has relationships with Adsilico Ltd and Health-Connect SA. Andrew Maidment has a relationship with Real Time Tomography, LLC Daimroc Imaging, LLC. Paul Kinahan has a relationship with PET/C LLC. Hilde Bosmans has a relationship with Qaelum NV and Qaelum Inc. Ehsan Samei has relationships with GE, Siemens, Imalogix, 12Sigma, SunNuclear, Metis Health Analytics, Silomedics, Cambridge University Press, and Wiley and Sons.

References

    1. Abadi E, Segars WP, Tsui BM, et al. Virtual clinical trials in medical imaging: a review. J Med Imaging. 2020;7(4):042805. - PMC - PubMed
    1. Badano A. In silico imaging clinical trials: cheaper, faster, better, safer, and more scalable. Trials. 2021;22(1):64. - PMC - PubMed
    1. Marshall N, Bosmans H. Performance evaluation of digital breast tomosynthesis systems: comparison of current virtual clinical trial methods. Phys Med Biol. 2022;67(22):22TR04. - PubMed
    1. Sizikova E, Saharkhiz N, Sharma D, et al. Knowledge-based in silico models and datasets for the comparative evaluation of mammography AI for a range of breast characteristics, lesion conspicuities, and doses. Oh A, Naumann T, Globerson A, Saenko K, Hardt M, Levine S eds. Advances in Neural Information Processing Systems Curran Associates, Inc. 2023;36:37401–37412. https://proceedings.neurips.cc/paper_files/paper/2023/file/75d0956c9594f...
    1. Tushar FI, Abadi E, Sotoudeh-Paima S, et al. Virtual vs. reality: external validation of COVID-19 classifiers using XCAT phantoms for chest computed tomography. In: Proceedings of SPIE Medical Imaging: Computer-Aided Diagnosis, SPIE—International Society for Optics and Photonics; 2022:32–38.